The ‘Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy’, recognized with the Diagnosis Award

The Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy has been awarded the Diagnosis Prize for Best Pharmaceutical Initiative, a recognition granted by Castilla y León Television that represents significant recognition for a project of great value to the healthcare system and, above all, to patients. It also represents an endorsement of the collaborative working model between agents in the healthcare system, as this guide is the result of joint work between the Spanish Society of Hospital Pharmacy (SEFH), the General Council of Pharmaceutical Associations, and Farmaindustria.

This award recognizes the key role played by hospital pharmacy services in the development of clinical trials and highlights the importance of harmonized, efficient, and patient-oriented processes. The guide—first published in 2022 and recently updated to incorporate aspects such as innovation, decentralization, environmental impact, and digitization—has become a reference tool for professionals, promoters, and institutions involved in clinical research in Spain.

The document has helped to standardize criteria, improve communication, optimize circuits, and advance the digitization of procedures, reinforcing Spain’s leadership as one of the most competitive countries in the world in clinical research. “Our country has established itself as one of the European and global leaders in clinical research, thanks to a very robust model of public-private collaboration that combines four key factors: the excellence of our healthcare professionals; a regulator and healthcare administrations committed to promoting research; a pharmaceutical industry that is committed to Spain and invests in our country and our healthcare system; and, last but not least, the generosity of the patients who participate in clinical trials,” said Amelia Martín Uranga, Director of Clinical and Translational Research at Farmaindustria, after receiving the award at the gala held on Thursday at the Liceo Theater in Salamanca and closed by the President of the Regional Government of Castile and León, Alfonso Fernández Mañueco.

“This guide was created precisely to reinforce that leadership position. It offers a set of specific best practices for hospital pharmacies, an essential area for clinical trials to function with quality, safety, and efficiency,” she added.

“We accept this award with great enthusiasm and pride, because it also recognizes a way of working that we at Farmaindustria have been promoting for years, through the creation of joint working groups with the different agents in the system, so that, through communication, collaboration, and the building of trust, we can continue to promote our leadership in an environment of strong international competition. Our commitment is to continue working hard so that current and future patients have more and better therapeutic alternatives,” added Martín Uranga.

The Diagnosis Awards, now in their third year, are aimed at professionals, companies, and institutions working in the field of health and healthcare. The winners in each of the categories in this year’s awards were chosen by an expert jury, following a selection of three finalists for each of the twelve categories.